Asthma - classification of severity & treatment Flashcards
Asthma classification is based on what 5 factors?
S-N-A-I-L Symptom occurrence, overall Nighttime awakenings Activities impacted Inhaler usage (rescue) Lung function
**SYMPTOMS and INHALER USE are the same values at each stage
ACTIVITY INTERFERENCE corresponds with asthma classification
Intermittent asthma features
S - symptoms 2 days or less/week
N - night awakening 2 nights or less/month
A - no activity limitation
I - inhaler use 2 days or less/week
L - FEV1 > 80%, normal between exacerbations
Mild persistent asthma features
S - symptoms > 2 days/week N - night awakening 3 to 4 nights/month A - mild limitation on activity I - inhaler > 2 days per week L - lung function FEV1 >80%
Moderate persistent asthma features
S - symptoms daily N - night awakening > 1 night/week A - moderate limitation on activity I - inhaler daily L - lung function FEV1 60 - 80%
Severe persistent asthma
S - symptoms throughout the day N - night awakening every night A - severe limitation on activity I - inhaler throughout the day L - lung function FEV1 <60%
Recommended step for starting treatment -
INTERMITTENT asthma
step 1
Recommended step for starting treatment -
MILD persisitent asthma
step 2
Recommended step for starting treatment -
MODERATE persistent asthma
step 3
Recommended step for starting treatment -
SEVERE persistent asthma
step 3 - 4 - or 5
Step 1 asthma treatment
all ages
SABA prn
Step 2 asthma treatment
all ages
SABA prn
+
< low dose ICS >
Step 3 asthma treatment
0-4 years old
SABA prn
+
< medium dose ICS >
Step 4 asthma treatment
0-4 years old
SABA prn \+ medium dose ICS \+ < LABA -or- montelukast >
Step 5 asthma treatment
0-4 years old
SABA prn \+ < high dose ICS > \+ LABA -or- montelukast
Step 6 asthma treatment
0-4 years old
SABA prn \+ high-dose ICS \+ LABA -or- montelukast \+ < oral corticosteroids >